Laura Biganzoli is the Director of the Medical Oncology Division and of the Breast Cancer Center at the Oncology Department of the Hospital of Prato – Italy. She is adjunct professor at the postgraduate school in medical oncology at the University of Florence.

She earned her medical degree at the University of Pavia, Italy in 1989 and completed fellowships at the National Cancer Institute of Milan, Italy and at the Jules Bordet Institute in Brussels, Belgium.

From 1996 to 2003 she worked as a senior staff member at the Medical Oncology Unit of the Jules Bordet Institute. Since the end of 2003 she started working at the Medical Oncology Department of the Hospital of Prato.

From 1998 to 2003, Dr. Biganzoli was the Director of the European Organisation for Research and Treatment of Cancer (EORTC) Investigational Drug Branch for Breast Cancer, dedicated to the conduction of early phase II studies in advanced breast cancer.

From 2009 to 2011 she was Visiting Senior Lecturer in the Division of Cancer Studies at the School of Medicine, King’s College – London.

Dr. Biganzoli sat on the Board of Directors of the Breast International Group (BIG) (1999-2003) and served in different scientific societies, i.e. faculty member of European Society of Medical Oncology (ESMO) for Elderly (2012-2014), Member of the Science and Education Committee of International Society of Geriatric Oncology (SIOG) (2014-2018, 2020-2022), faculty member for the Breast Cancer Faculty Group of ESMO (2017-2018). From 2017 to 2020 she served as President of the European Society of Breast Cancer Specialists (EUSOMA).

At present, Dr. Biganzoli is the ESMO Co-Chair of the ESMO/SIOG Cancer in the Elderly Working Group, member of the SIOG Board of Directors, and Board member of the “Gruppo italiano di Oncologia Geriatrica” (GIOGer).

She is a member of the writing committee of the national guidelines of the “Associazione Italiana di Oncologia Medica” (AIOM) and a member of the Advanced Breast Cancer (ABC) Consensus Panel.

Her research focuses on breast cancer and geriatric oncology and she has extensively lectured and published in these fields.